Publications by authors named "Thomas Raber"

Claim this Profile
C
Calculating the individual probability of successful ocriplasmin treatment in eyes with vitreomacular traction-Validation and refinement of a multivariable prediction model.
Christoph Paul, Hans-Helge Müller, Thomas Raber, Thomas Bertelmann,

PLoS One· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting the individual probability of macular hole closure following intravitreal ocriplasmin injections for vitreomacular traction release using baseline characteristics.
Thomas Bertelmann, Lars Berndzen, Thomas Raber, Sebastian Pfeiffer, Andreas Leha

Sci Rep· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OCRIPLASMIN FOR VITREOMACULAR TRACTION IN CLINICAL PRACTICE: The INJECT Study.
David H W Steel, Niall Patton, Theodor Stappler, Niral Karia, Hans Hoerauf, Thomas Raber

Retina· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Factors Associated with Ocriplasmin Efficacy for the Treatment of Symptomatic Vitreomacular Adhesion and Full-thickness Macular Hole: Analysis from Four Studies.
Brian C Joondeph, Paul Willems, Thomas Raber, Luc Duchateau, Joseph Markoff

J Ophthalmic Vis Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of the trypanocidal drug melarsoprol and its conversion products in biological fluids with HPLC-ICPMS/ESMS.
Georg Raber, Thomas Raber, Reingard Raml, Manuela Murko, Christoph Magnes

Talanta· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of the fixed combination of brinzolamide 1% and timolol 0.5% in daily practice.
Ines Lanzl, Thomas Raber

Clin Ophthalmol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Observational study results in glaucoma patients undergoing a regimen replacement to fixed combination travoprost 0.004%/timolol 0.5% in Germany.
Kay-Oliver Arend, Thomas Raber

J Ocul Pharmacol Ther· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis